Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Anti-lipolysis-stimulated lipoprotein receptor antibody-drug conjugate to treat triple-negative breast cancer

Anti-lipolysis-stimulated lipoprotein receptor antibody-drug conjugate to treat triple-negative breast cancer

Investigators

Davis Ballard, Advisor: X. Margaret Liu
Lufang Zhou, Professor
X. Margaret Liu, Professor
Zhuoxin Zora Zhou
Tanvi Varadkar
Jiashuai Zhang
Zhantao Du
Ashley George
Aaron Krabacher
Rachel Yengo

Filters: 2025